BBL
WST icon

Beck Bode LLC’s West Pharmaceutical WST Stock Holding History

Beck Bode LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,632
Closed -$1.4M – 258
2022
Q2 		$1.4M Sell
4,632
-80
-2% -$26K 0.3% 74
2022
Q1 		$1.94M Sell
4,712
-8
-0.2% -$3.13K 0.44% 50
2021
Q4 		$2.21M Buy
+4,720
New +$2.03M 0.55% 40
2021
Q3 		– Sell
-285
Closed -$102K – 313
2021
Q2 		$102K Buy
+285
New +$94.2K 0.03% 97
2020
Q4 		– Sell
-201
Closed -$55K – 285
2020
Q3 		$55K Buy
+201
New +$53.2K 0.02% 101

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's WST Position: Q3 2022 in Review

Beck Bode LLC sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 4,632 shares — an estimated $1.4M sold.

Beck Bode LLC first reported a position in WST in Q3 2020 and held it in 5 quarters. The position peaked at $2.21M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Beck Bode LLC reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Beck Bode LLC sold 4,632 West Pharmaceutical shares in Q3 2022, an estimated $1.4M.
  • Beck Bode LLC first reported a position in West Pharmaceutical in Q3 2020 and held it in 5 quarters.
  • Beck Bode LLC's West Pharmaceutical position peaked at $2.21M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Beck Bode LLC's 13F filing for Q3 2022, filed 14 Nov 2022.